Verified Nov 2026
Other
·
Carlsbad, California
·
Since 2010
GenMark Diagnostics is a molecular diagnostics company headquartered in Carlsbad, California, founded in 2010. It develops automated, multiplex molecular tests using its proprietary eSensor electrochemical detection technology, including the ePlex and XT-8 instrument systems. The company has between 200 and 500 employees, reports revenue in the range of 171.6 million, and is listed publicly under the ticker GNMK. It serves the medical sector, with additional listed industries including automotive, electronics, and industrial equipment. The company is now a subsidiary of Roche Holding AG.
GenMark Diagnostics at a glance
Revenue
171.6M
Employees
200-500
Founded
2010
Headquarters
Carlsbad, California
Ownership
Publicly traded (NASDAQ: GNMK)
Certifications
ISO 13485
Import activity
23
Industries
Automotive
Electric Vehicles
Electronics
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
23
Named foreign suppliers
4
Top origins
Costa Rica · Belgium · Singapore · Germany
Shared foreign counterparties do not establish that these companies buy from GenMark Diagnostics.
What this tells a buyer
A LinkedIn post dated August 31, 2025 reported a strategic acquisition of GenMark Diagnostics, and the company is now a subsidiary of Roche Holding AG.
GenMark holds ISO 13485 certification and offers the ePlex System for rapid respiratory and bloodstream infection testing alongside the XT-8 System for respiratory virus detection.
The company is listed publicly under the ticker GNMK and reports revenue in the range of 171.6 million, with 200 to 500 employees.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
16 years in operation (founded 2010).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
GenMark Diagnostics is a molecular diagnostics company headquartered in Carlsbad, California, founded in 2010. It develops automated, multiplex molecular tests using its proprietary eSensor electrochemical detection technology, including the ePlex and XT-8 instrument systems. The company has between 200 and 500 employees, reports revenue in the range of 171.6 million, and is listed publicly under the ticker GNMK. It serves the medical sector, with additional listed industries including automotive, electronics, and industrial equipment. The company is now a subsidiary of Roche Holding AG.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Carlsbad, California |
Employees | 200-500 |
Revenue | 171.6M |
Ownership | Publicly traded (NASDAQ: GNMK) |
Certifications | ISO 13485 |
What GenMark Diagnostics makes
GenMark holds ISO 13485 certification and offers the ePlex System for rapid respiratory and bloodstream infection testing alongside the XT-8 System for respiratory virus detection.
Certifications
GenMark Diagnostics is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — roche.com
Trade and customs footprint
A LinkedIn post dated August 31, 2025 reported a strategic acquisition of GenMark Diagnostics, and the company is now a subsidiary of Roche Holding AG. US customs bill-of-lading records list 23 inbound shipments across 4 foreign suppliers, with top origins including Costa Rica · Belgium · Singapore · Germany.
Latest developments
2026-10-06 — We are currently looking for a Technical Product Lead (ePlex) to join my team at GenMark Diagnostics (Roche) in Carlsbad, CA. This is a key leadership position with end-to-end technical ownership of … | Mariella Pfeiffer (linkedin.com)
2025-12-17 — We’re hiring a Process Engineering Intern for Summer 2026 to join our Automation Engineering team at GenMark Diagnostics. A great opportunity to learn about process development and automation! | Minh L. (linkedin.com)
2025-10-02 — Scott O'Brien gave a real deep dive into the tactics and culture that made GenMark Diagnostics successful, this week on Diagnosing Dx | David Filby (linkedin.com)
2025-09-30 — Workflow, Customers, and Course Corrections: Scott O’Brien on Scaling Genmark with Scott O'Brien | David Filby (linkedin.com)
2025-08-31 — 🎉 Congratulations to on their strategic acquisition of GenMark Diagnostics. | Sushil Thapa (linkedin.com)
2025-08-23 — Happy to be part of another step in the story of Roche and GenMark now.GenMark Diagnostics Is Now Part of the Roche Group | Fabio Marcone (Mascagna) (linkedin.com)
Company details
The company is listed publicly under the ticker GNMK and reports revenue in the range of 171.6 million, with 200 to 500 employees. GenMark Diagnostics was founded in 2010, has an estimated 200-500 employees, and is headquartered in Carlsbad, California. On the LightSource stability read it is rated "Established & strong": 16 years in operation (founded 2010). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does GenMark Diagnostics do?
GenMark Diagnostics is a molecular diagnostics company headquartered in Carlsbad, California, founded in 2010. It develops automated, multiplex molecular tests using its proprietary eSensor electrochemical detection technology, including the ePlex and XT-8 instrument systems. The company has between 200 and 500 employees, reports revenue in the range of 171.6 million, and is listed publicly under the ticker GNMK. It serves the medical sector, with additional listed industries including automotive, electronics, and industrial equipment. The company is now a subsidiary of Roche Holding AG.
Where is GenMark Diagnostics headquartered?
GenMark Diagnostics is headquartered in Carlsbad, California (5964 La Place Ct, Carlsbad, California, 92008-8829).
When was GenMark Diagnostics founded?
GenMark Diagnostics was founded in 2010.
How big is GenMark Diagnostics?
GenMark Diagnostics has an estimated 200-500 employees, with revenue in the 171.6M range.
Is GenMark Diagnostics publicly traded?
Publicly traded (NASDAQ: GNMK). Public financial figures are drawn from its filings.
What certifications does GenMark Diagnostics hold?
GenMark Diagnostics lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.